Publications
Hemarina est une société de biotechnologie qui possède une forte activité de R&D. Nos équipes possèdent un savoir faire unique, basé sur une quinzaine d'années de recherche fondamentale. Les résultats de nos travaux de recherche font l’objet de nombreux articles scientifiques publiés dans des journaux de premier plan.
Technologie Hemarina
Ali, A., Watanabe, Y., Galasso, M., Stansfield, W., Watanabe, T., Ramandan, K., Chen, M., Ribeiro, R.P., Gokhale, H., Gazzalle, A., Waddell, T., Liu, M., Keshavjee, S., Cypel, M.
Two-Day Lung Preservation Followed by Lung Transplantation in a Large Animal Model Using Novel Extracellular Oxygen Carrier.
The Journal of Heart and Lung Transplantation, - 2018
https://www.jhltonline.org/article/S1053-2498(18)30296-1/abstract
Lemaire, F., Bietiger, W., Peronet, C., Langlois, A., Mura, C., Bouzakri, K., Sigrist, S., Polard, V., Zal, F., Pinget, M., and Maillard, E.
Effect of HEMO2life®, a marine oxygen carrier, for pancreas preservation during cold ischemia.
Poster presented during 8th international EPITA Symposium, Innsbruck, Austria. - 2018
Le Pape, F., Richard, G., Porchet, E., Sourice, S., Dubrana, F., Férec, C., Polard, V., Pace, R., Weiss, P., Zal, F., Delépine, P., Leize, E.
Adhesion, proliferation and osteogenic differentiation of human MSCs cultured under perfusion with a marine oxygen carrier on an allogenic bone substitute.
Artificial Cells, Nanomedicine, and Biotechnology, 46(1):95-107. - 2018
https://www.ncbi.nlm.nih.gov/pubmed/28830269
Marchand, A., Crepin, N., Roulland, I., Semence, F., Domergue, V., Zal, F., Polard, V., Coquerel, A.
Application of HBOCs electrophoretic method to detect a new blood substitute derived from the giant extracellular hemoglobin of lugworm.
Drug Testing and Analysis, 9(11-12):1762-1767. - 2017
https://www.ncbi.nlm.nih.gov/pubmed/27787946
Moon-Massat, P., Mullah, S.H., Abutarboush, R., Saha, B.K., Pappas, G., Haque, A., Auker, C., McCarron, R.M., Arnaud, F., Scultetus, A.
Cerebral Vasoactivity and Oxygenation with Oxygen Carrier M101 in Rats.
Journal of Neurotrauma, 34(19):2812-2822. - 2017
https://www.ncbi.nlm.nih.gov/pubmed/26161914
Teh, E. S., Zal, F., Polard, V., Menasché, P., Chambers, D.J.
HEMO2life® as a protective additive to Celsior solution for static storage of donor hearts prior to transplantation.
Artificial Cells, Nanomedicine, and Biotechnology, 45(4):717-722. - 2017
https://www.ncbi.nlm.nih.gov/pubmed/28079401
Le Pape, F., Cosnuau-Kemmat, L., Richard, G., Dubrana, F., Férec, C., Zal, F., Leize, E., Delépine, P.
HEMOXCell, a New Oxygen Carrier Usable as an Additive for Mesenchymal Stem Cell Culture in Platelet Lysate-Supplemented Media.
Artificial Organs, 41(4):359-371. - 2017
https://www.ncbi.nlm.nih.gov/pubmed/28326561
Rodriguez-Brotons, A., Bietiger, W., Peronet, C., Langlois, A., Magisson, J., Mura, C., Sookhareea, C., Polard, V., Jeandidier, N., Zal, F., Pinget, M., Sigrist, S., Maillard, E.
Comparison of Perfluorodecalin and HEMOXCell as Oxygen Carriers for Islet Oxygenation in an In Vitro Model of Encapsulation.
Tissue Engineering Part A, 22(23-24):1327-1336 - 2016
https://www.ncbi.nlm.nih.gov/pubmed/27796164
Le Pape, F., Bossard, M., Dutheil, D., Rousselot, M., Polard, V., Férec, C., Leize, E., Delépine, P., Zal, F.
Advancement in recombinant protein production using a marine oxygen carrier to enhance oxygen transfer in a CHO-S cell line.
Artificial Cells, Nanomedicine, and Biotechnology, 43(3):186-195. - 2015
https://www.ncbi.nlm.nih.gov/pubmed/25961365